Arleevskaya, M.I.; Boulygina, E.A.; Larionova, R.; Validov, S.; Kravtsova, O.; Shagimardanova, E.I.; Velo, L.; Hery-Arnaud, G.; Carlé, C.; Renaudineau, Y.
Anti-Citrullinated Peptide Antibodies Control Oral Porphyromonas and Aggregatibacter species in Patients with Rheumatoid Arthritis. Int. J. Mol. Sci. 2022, 23, 12599.
https://doi.org/10.3390/ijms232012599
AMA Style
Arleevskaya MI, Boulygina EA, Larionova R, Validov S, Kravtsova O, Shagimardanova EI, Velo L, Hery-Arnaud G, Carlé C, Renaudineau Y.
Anti-Citrullinated Peptide Antibodies Control Oral Porphyromonas and Aggregatibacter species in Patients with Rheumatoid Arthritis. International Journal of Molecular Sciences. 2022; 23(20):12599.
https://doi.org/10.3390/ijms232012599
Chicago/Turabian Style
Arleevskaya, Marina I., Eugenia A. Boulygina, Regina Larionova, Shamil Validov, Olga Kravtsova, Elena I. Shagimardanova, Lourdes Velo, Geneviève Hery-Arnaud, Caroline Carlé, and Yves Renaudineau.
2022. "Anti-Citrullinated Peptide Antibodies Control Oral Porphyromonas and Aggregatibacter species in Patients with Rheumatoid Arthritis" International Journal of Molecular Sciences 23, no. 20: 12599.
https://doi.org/10.3390/ijms232012599
APA Style
Arleevskaya, M. I., Boulygina, E. A., Larionova, R., Validov, S., Kravtsova, O., Shagimardanova, E. I., Velo, L., Hery-Arnaud, G., Carlé, C., & Renaudineau, Y.
(2022). Anti-Citrullinated Peptide Antibodies Control Oral Porphyromonas and Aggregatibacter species in Patients with Rheumatoid Arthritis. International Journal of Molecular Sciences, 23(20), 12599.
https://doi.org/10.3390/ijms232012599
